{"id":"https://openalex.org/W4361237662","doi":"https://doi.org/10.1158/0008-5472.22416750.v1","title":"Supplementary Figures and Tables from OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues","display_name":"Supplementary Figures and Tables from OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237662","doi":"https://doi.org/10.1158/0008-5472.22416750.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22416750.v1","doi":"https://doi.org/10.1158/0008-5472.22416750.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22416750.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.22416750.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114046364","display_name":"Christina Diane Drenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina D. Drenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Alice A. Gibson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice A. Gibson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003188148","display_name":"Stanley B. Pounds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley B. Pounds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081717281","display_name":"Lei Shi","orcid":"https://orcid.org/0000-0002-3820-3693","observed_orcids":["https://orcid.org/0000-0002-3820-3693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lei Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068743574","display_name":"Dena P. Rhinehart","orcid":"https://orcid.org/0009-0007-9154-9232","observed_orcids":["https://orcid.org/0009-0007-9154-9232"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dena P. Rhinehart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016647580","display_name":"Lie Li","orcid":"https://orcid.org/0000-0003-1508-5484","observed_orcids":["https://orcid.org/0000-0003-1508-5484"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lie Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077821599","display_name":"Guoqing Du","orcid":"https://orcid.org/0000-0001-7963-4652","observed_orcids":["https://orcid.org/0000-0001-7963-4652"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guoqing Du","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065181138","display_name":"Anne T. Nies","orcid":"https://orcid.org/0000-0001-6862-0730","observed_orcids":["https://orcid.org/0000-0001-6862-0730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne T. Nies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057183308","display_name":"Matthias Georg Schwab","orcid":"https://orcid.org/0000-0002-9984-075X","observed_orcids":["https://orcid.org/0000-0002-9984-075X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthias Schwab","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063733931","display_name":"Navjotsingh Pabla","orcid":"https://orcid.org/0000-0001-9408-0539","observed_orcids":["https://orcid.org/0000-0001-9408-0539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Navjotsingh Pabla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004524654","display_name":"William G. Blum","orcid":"https://orcid.org/0000-0003-0111-7465","observed_orcids":["https://orcid.org/0000-0003-0111-7465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Blum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028885623","display_name":"Tanja Andrea Gruber","orcid":"https://orcid.org/0000-0003-1072-7257","observed_orcids":["https://orcid.org/0000-0003-1072-7257"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanja A. Gruber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/octn1","display_name":"OCTN1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nucleoside-transporters","display_name":"nucleoside transporters","score":0.8190000057220459},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.9290000200271606},{"id":"https://openalex.org/keywords/drug-uptake","display_name":"drug uptake","score":0.9399999976158142},{"id":"https://openalex.org/keywords/ergothioneine","display_name":"ergothioneine","score":0.8569999933242798},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.8799999952316284},{"id":"https://openalex.org/keywords/nci-60-cell-lines","display_name":"NCI-60 cell lines","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2777771644","wikidata":"https://www.wikidata.org/wiki/Q614788","display_name":"Ergothioneine","level":3,"score":0.522250235080719},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5045679807662964},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.48954471945762634},{"id":"https://openalex.org/C40875361","wikidata":"https://www.wikidata.org/wiki/Q2356542","display_name":"Reagent","level":2,"score":0.471809983253479},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3235771656036377},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.28293028473854065},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26954054832458496},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14250248670578003},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.22416750.v1","doi":"https://doi.org/10.1158/0008-5472.22416750.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22416750.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22416750","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_and_Tables_from_OCTN1_Is_a_High-Affinity_Carrier_of_Nucleoside_Analogues/22416750","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22416750.v1","doi":"https://doi.org/10.1158/0008-5472.22416750.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22416750.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361236834","https://openalex.org/W2588008686","https://openalex.org/W2931654306","https://openalex.org/W7096171968","https://openalex.org/W2753214060","https://openalex.org/W2066537745","https://openalex.org/W2094813554","https://openalex.org/W2049968732","https://openalex.org/W2097664002","https://openalex.org/W2294686096"],"abstract_inverted_index":{"This":[0],"file":[1],"contains":[2],"supplementary":[3],"information":[4],"regarding":[5],"materials":[6],"and":[7,11,23],"methods":[8],"including:":[9],"chemicals":[10],"reagents,":[12],"early":[13],"drug":[14],"uptake,":[15],"NCI60":[16],"correlation":[17],"analysis,":[18],"quantitative":[19],"determination":[20],"of":[21],"ergothioneine,":[22],"culturing":[24],"keratinocytes.":[25]},"counts_by_year":[],"updated_date":"2026-10-05T09:50:58.205359","created_date":"2023-03-31T00:00:00"}